Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.09 +1.5%	$2.12	$0.76 ▼ $2.73	$79.04M	1.39	101,123 shs	36,763 shs
DRTS Alpha Tau Medical	$3.16 +0.6%	$3.10	$2.11 ▼ $4.39	$268.03M	0.99	61,823 shs	79,153 shs
NPCE NeuroPace	$8.99 +4.3%	$9.57	$5.45 ▼ $18.98	$297.39M	1.89	205,626 shs	156,232 shs
TCMD Tactile Systems Technology	$13.23 +4.2%	$10.78	$8.61 ▼ $21.10	$294.90M	0.96	269,039 shs	192,645 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-3.24%	-17.72%	+35.71%	+60.77%
DRTS Alpha Tau Medical	0.00%	-3.66%	+3.27%	+5.33%	+43.64%
NPCE NeuroPace	0.00%	+5.02%	+0.11%	-49.15%	+13.51%
TCMD Tactile Systems Technology	0.00%	+6.61%	+25.40%	+40.45%	+1.38%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APYX Apyx Medical	1.6916 of 5 stars	0.0	3.0	4.2	2.1	1.7	0.6
DRTS Alpha Tau Medical	2.6601 of 5 stars	3.5	5.0	0.0	1.3	1.7	0.0
NPCE NeuroPace	3.3483 of 5 stars	3.4	3.0	0.0	3.2	3.3	0.6
TCMD Tactile Systems Technology	2.4574 of 5 stars	1.2	3.0	0.0	2.4	2.5	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.67	Moderate Buy	N/A	N/A
DRTS Alpha Tau Medical	3.00	Buy	$9.00	184.81% Upside
NPCE NeuroPace	2.83	Moderate Buy	$16.60	84.65% Upside
TCMD Tactile Systems Technology	2.40	Hold	$13.50	2.04% Upside

Current Analyst Ratings Breakdown

Latest APYX, NPCE, DRTS, and TCMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	NPCE NeuroPace	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/13/2025	NPCE NeuroPace	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$17.00 ➝ $15.00
8/5/2025	TCMD Tactile Systems Technology	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/5/2025	TCMD Tactile Systems Technology	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$12.00 ➝ $13.00
5/28/2025	NPCE NeuroPace	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$18.00

(Data available from 8/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$48.10M	1.64	N/A	N/A	$0.38 per share	5.50
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.89 per share	N/A
NPCE NeuroPace	$79.91M	3.72	N/A	N/A	$0.27 per share	33.30
TCMD Tactile Systems Technology	$292.98M	1.01	$1.08 per share	12.22	$9.03 per share	1.47

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$23.46M	-$0.45	N/A	N/A	N/A	-37.11%	-158.22%	-28.30%	11/7/2025 (Estimated)
DRTS Alpha Tau Medical	-$31.75M	-$0.48	N/A	N/A	N/A	N/A	-51.21%	-38.18%	N/A
NPCE NeuroPace	-$27.14M	-$0.84	N/A	N/A	N/A	-29.29%	-168.61%	-25.48%	11/11/2025 (Estimated)
TCMD Tactile Systems Technology	$16.96M	$0.62	21.34	15.75	N/A	5.06%	7.72%	5.59%	11/3/2025 (Estimated)

Latest APYX, NPCE, DRTS, and TCMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	NPCE NeuroPace	-$0.24	-$0.26	-$0.02	-$0.26	$23.08 million	$23.52 million
8/11/2025	Q2 2025	DRTS Alpha Tau Medical	-$0.12	-$0.13	-$0.01	-$0.13	N/A	N/A
8/7/2025	Q2 2025	APYX Apyx Medical	-$0.0933	-$0.09	+$0.0033	-$0.09	$11.69 million	$11.37 million
8/4/2025	Q2 2025	TCMD Tactile Systems Technology	$0.09	$0.14	+$0.05	$0.14	$73.93 million	$78.91 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
NPCE NeuroPace	N/A	N/A	N/A	N/A	N/A
TCMD Tactile Systems Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	4.61	4.72	3.95
DRTS Alpha Tau Medical	0.07	10.52	5.81
NPCE NeuroPace	3.02	5.47	4.51
TCMD Tactile Systems Technology	0.11	3.79	3.36

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
DRTS Alpha Tau Medical	2.65%
NPCE NeuroPace	78.83%
TCMD Tactile Systems Technology	83.43%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.20%
DRTS Alpha Tau Medical	39.50%
NPCE NeuroPace	20.50%
TCMD Tactile Systems Technology	2.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	270	37.82 million	32.07 million	Optionable
DRTS Alpha Tau Medical	80	84.82 million	51.32 million	No Data
NPCE NeuroPace	170	33.08 million	26.30 million	Optionable
TCMD Tactile Systems Technology	1,037	22.29 million	21.74 million	Optionable

APYX, NPCE, DRTS, and TCMD Headlines

Recent News About These Companies

Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?

August 22 at 10:40 AM | zacks.com

Tactile Systems Technology, Inc. $TCMD Shares Sold by Tocqueville Asset Management L.P.

August 20, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) CEO Sheri Louise Dodd Sells 7,762 Shares

August 14, 2025 | marketbeat.com

Koss Olinger Consulting LLC Takes Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

August 11, 2025 | marketbeat.com

Blair William & Co. IL Reduces Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

August 10, 2025 | marketbeat.com

Tactile Systems Technology (NASDAQ:TCMD) Upgraded by Wall Street Zen to Buy Rating

August 10, 2025 | marketbeat.com

What is B. Riley's Estimate for TCMD Q1 Earnings?

August 8, 2025 | marketbeat.com

Q3 Earnings Forecast for TCMD Issued By William Blair

August 8, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from Analysts

August 7, 2025 | marketbeat.com

William Blair Upgrades Tactile Systems Technology (NASDAQ:TCMD) to Strong-Buy

August 7, 2025 | marketbeat.com

B. Riley Analysts Reduce Earnings Estimates for TCMD

August 7, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Call Transcript

August 7, 2025 | msn.com

B. Riley Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock Price

August 6, 2025 | marketbeat.com

Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now?

August 6, 2025 | zacks.com

Tactile Systems Technology (TCMD) Just Overtook the 20-Day Moving Average

August 6, 2025 | zacks.com

Tactile Systems Technology (TCMD) Recently Broke Out Above the 50-Day Moving Average

August 6, 2025 | zacks.com

Tactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growth

August 6, 2025 | msn.com

Tactile Systems Technology (NASDAQ:TCMD) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

August 5, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call Transcript

August 4, 2025 | seekingalpha.com

Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates

August 4, 2025 | zacks.com

Tactile Systems (TCMD) Q2 Revenue Up 8%

August 4, 2025 | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX, NPCE, DRTS, and TCMD Company Descriptions

Apyx Medical NASDAQ:APYX

$2.09 +0.03 (+1.46%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$2.09 0.00 (0.00%)

As of 08/22/2025 04:27 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Alpha Tau Medical NASDAQ:DRTS

$3.16 +0.02 (+0.64%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$3.19 +0.03 (+0.95%)

As of 08/22/2025 04:04 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

NeuroPace NASDAQ:NPCE

$8.99 +0.37 (+4.29%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$9.00 +0.01 (+0.11%)

As of 04:00 AM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Tactile Systems Technology NASDAQ:TCMD

$13.23 +0.53 (+4.17%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$13.22 -0.01 (-0.11%)

As of 04:26 AM Eastern

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time